Literature DB >> 7965785

Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo.

M Sugiura1, Y Shoyama, H Saito, K Abe.   

Abstract

The effects of crocin (crocetin di-gentiobiose ester) and its analogs on long-term potentiation (LTP) of evoked potential in the dentate gyrus were investigated by using anesthetized rats. Intracerebroventricular injection of crocin (51.2 nmol) alone did not affect the synaptic potential evoked by single stimulation of the medial perforant path, and neither inhibited nor facilitated the LTP induced by strong (30 pulses at 60 Hz) or weak (20 pulses at 60 Hz) tetanus. Administration of ethanol (30 v/v%, 2 ml/kg i.v.) blocked the LTP induced by application of tetanus (30 pulses at 60 Hz), but the LTP-blocking effect of ethanol was prevented by preadministration of crocin (51.2 nmol i.c.v.). Crocetin gentiobiose glucose ester also antagonized the LTP-blocking effect of ethanol, but it required a higher dose (102.5 nmol i.c.v.) to exhibit a more significant effect than crocin. Crocetin di-glucose ester at a dose up to 102.5 nmol (i.c.v.) did not significantly affect the LTP-blocking effect of ethanol. Neither gentiobiose alone (102.5 nmol i.c.v.) nor glucose alone (204.9 nmol i.c.v.) mimicked the activity of crocin. These results suggest that crocin can prevent the ethanol-induced impairment of hippocampal synaptic plasticity in vivo and that gentiobioses attached to the fatty acid chain are important for crocin to exert the biological activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965785

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

2.  Effects and mechanism of Weinaokang on reperfusion-induced vascular injury to cerebral microvessels after global cerebral ischemia.

Authors:  Yong-qiu Zheng; Jian-xun Liu; Xin-zhi Li; Li Xu
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

3.  PC-2, linear homoglucan with alpha-linkages, peripherally enhances the hippocampal long-term potentiation.

Authors:  M Smriga; H Saito; S Shibata; T Narui; T Okuyama; N Nishiyama
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

4.  Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats.

Authors:  Mohsen Khalili; Faezeh Hamzeh
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

Review 5.  Crocetin: an agent derived from saffron for prevention and therapy for cancer.

Authors:  William G Gutheil; Gregory Reed; Amitabha Ray; Shrikant Anant; Animesh Dhar
Journal:  Curr Pharm Biotechnol       Date:  2012-01       Impact factor: 2.837

6.  Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats.

Authors:  Georgia Georgiadou; Vasilios Grivas; Petros A Tarantilis; Nikolaos Pitsikas
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

7.  New minor glycoside components from saffron.

Authors:  Nguyen Huu Tung; Yukihiro Shoyama
Journal:  J Nat Med       Date:  2012-11-21       Impact factor: 2.343

8.  Preparation of monoclonal antibody against crocin and its characterization.

Authors:  L Xuan; H Tanaka; Y Xu; Y Shoyama
Journal:  Cytotechnology       Date:  1999-01       Impact factor: 2.058

Review 9.  Saffron in phytotherapy: pharmacology and clinical uses.

Authors:  Mathias Schmidt; Georges Betti; Andreas Hensel
Journal:  Wien Med Wochenschr       Date:  2007

10.  Effect of Aqueous Extract of Crocus sativus L. on Morphine-Induced Memory Impairment.

Authors:  Sayede Maryam Naghibi; Mahmoud Hosseini; Fatemeh Khani; Motahare Rahimi; Farzaneh Vafaee; Hassan Rakhshandeh; Azita Aghaie
Journal:  Adv Pharmacol Sci       Date:  2012-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.